A rapid response of lung squamous cell carcinoma following treatment with sintilimab combined with recombinant humane endostatin injection and nab-paclitaxel in an elderly patient: A case report.
Yueyu FangHui SunYi ChenNanyuan JiangLianhua JiJunfeng ShiPublished in: Medicine (2021)
Sintilimab combined with endostar and nab-paclitaxel may be a good treatment option for lung squamous cell cancer, especially for that in elderly patients.